by Zena Sfeir | Jun 9, 2022 | Press Releases
Somerville, MA, June 9, 2022 : GNS today announced that John Maraganore, PhD, biopharma industry leader and the former founding CEO of Alnylam Pharmaceuticals, has joined GNS as a strategic advisor. “John is a visionary and an inspiration for the biopharma industry...
by Zena Sfeir | Jun 1, 2022 | Press Releases
3-year partnership will leverage biomarker database and AI for innovation to create “Digital Twins” that help uncover the complex biology driving Alzheimer’s Disease Somerville, MA, June 1st, 2022 : GNS, the leader in the use of “Virtual Patients,” Causal AI and...
by Zena Sfeir | May 9, 2022 | Press Releases
Somerville, MA, May 9, 2022 : GNS Healthcare, the leader in the use of “Virtual Patients”, Causal AI and simulation technology for biopharmaceutical companies, today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company...
by Zena Sfeir | Apr 13, 2022 | Press Releases
Somerville, MA, April 13, 2022 : GNS Healthcare, the leader in the use of “Virtual Patients” and Causal AI and simulation technology for biopharmaceutical companies, today announced the hiring of Joseph F. Donahue as Chief Business Officer. In this role, Mr. Donahue...
by Jerome Windsor | Nov 4, 2021 | Press Releases
– Partnership leverages Scipher Medicine’s proprietary patient clinico-genomic data – In silico patient models enable pharmaceutical companies to understand what disease treatments work for which patients and why Somerville, Mass., and Waltham,...
by Jerome Windsor | Oct 4, 2021 | Press Releases
Collaboration with Memorial Sloan Kettering Cancer Center’s Innovation Hub aims to answer key questions in prostate cancer patient care and accelerate discovery and development of new treatments Somerville, Mass.– October 5, 2021– GNS Healthcare (GNS), an artificial...
